These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16940943)

  • 1. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of molecular biology studies to gene therapy treatment strategies.
    Gustin A; Pederson L; Miller R; Chan C; Vickers SM
    World J Surg; 2002 Jul; 26(7):854-60. PubMed ID: 11960211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
    Sakorafas GH; Tsiotou AG; Tsiotos GG
    Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of pancreatic cancer.
    Inoue S; Tezel E; Nakao A
    Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowskal H; Strzelczyk J; Janiak A; Malecka-Panas E
    Hepatogastroenterology; 2006; 53(70):608-12. PubMed ID: 16995472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
    Eskelinen MJ; Haglund UH
    Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
    Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
    Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New molecular targets in pancreatic cancer].
    Torrisani J; Bournet B; Cordelier P; Buscail L
    Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma.
    Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO
    Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic basis of pancreatic adenocarcinoma.
    Hilgers W; Kern SE
    Genes Chromosomes Cancer; 1999 Sep; 26(1):1-12. PubMed ID: 10440999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-family gene amplification and expression in resected pancreatic cancer.
    te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ
    Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of pancreatic cancer.
    Maitra A; Kern SE; Hruban RH
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of pancreatic cancer.
    Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
    Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular prognostic markers in pancreatic cancer.
    Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
    J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications.
    Sakorafas GH; Tsiotou AG
    Eur J Surg; 1994 Oct; 160(10):529-34. PubMed ID: 7849153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral gene therapy for pancreatic cancer: where do we stand?
    Kuhlmann KF; Gouma DJ; Wesseling JG
    Dig Surg; 2008; 25(4):278-92. PubMed ID: 18635930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of pancreatic cancer.
    Choudhuri G; Singh D
    Trop Gastroenterol; 2005; 26(3):111-4. PubMed ID: 16512456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.